123I-MIBG imaging detects cardiac involvement and predicts cardiac events in Churg-Strauss syndrome

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 2, 2011, Pages 221-229

  Horiguchi, Yoriko ^a   Morita, Yukiko ^a   Tsurikisawa, Naomi ^a   Akiyama, Kazuo ^a  

^a SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

123I MIBG; Cardiac disease; Cardiac sympathetic nerve; Churg Strauss syndrome; Scintigraphy

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BRAIN NATRIURETIC PEPTIDE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; STEROID; THALLIUM 201; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SPARTIC ANGINA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EVENT FREE SURVIVAL; FEMALE; HEART; HEART DISEASE; HEART FAILURE; HEART INJURY; HEART RATE; HEART SCINTISCANNING; HUMAN; MALE; MEDIASTINUM; MYOCARDIAL PERFUSION IMAGING; PERICARDITIS; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC NERVE; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; ADULT; AGED; CHURG-STRAUSS SYNDROME; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79551544578     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1617-8     Document Type: Article

References (32)

1. JC Jennette RJ Falk K Andrassy PA Bacon J Churg WL Gross, et al. 1994 Nomenclature of systemic vasculitides. Proposal of an international consensus conference Arthritis Rheum 37 187 192 1:STN:280:DyaK2c7nsF2mug%3D%3D 10.1002/art.1780370206 8129773
2. RM Martin LV Wilton RD Mann 1999 Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies Pharmacoepidemiol Drug Saf 8 179 189 1:STN:280:DC%2BD2c7nvFSktQ%3D%3D 10.1002/(SICI)1099-1557(199905/06)8: 3<179::AID-PDS414>3.0.CO;2-K 15073927 (Pubitemid 29286530)
3. RA Watts SE Lane G Bentham DG Scott 2000 Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom Arthritis Rheum 43 414 419 1:STN:280:DC%2BD3c7lsFGmsg%3D%3D 10.1002/1529-0131(200002)43:2<414::AID- ANR23>3.0.CO;2-0 10693883 (Pubitemid 30395752)
4. RA Sinico LD Toma U Maggiore P Bottero A Radice C Tosoni, et al. 2005 Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome Arthritis Rheum 52 2926 2935 1:CAS:528: DC%2BD2MXhtFeltrbO 10.1002/art.21250 16142760 (Pubitemid 41369124)
5. L Guillevin P Cohen M Gayraud F Lhote B Jarrousse P Casassus 1999 Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients Medicine (Baltimore) 78 26 37 1:STN:280:DyaK1M7ksVWlsQ%3D%3D 10.1097/00005792-199901000-00003 (Pubitemid 29065978)
6. J Churg L Strauss 1951 Allergic granulomatosis, allergic angiitis, and periarteritis nodosa Am J Pathol 27 277 301 1:STN:280:DyaG3M%2FkvVyisw%3D%3D 14819261
7. I Noth ME Strek AR Leff 2003 Churg-Strauss syndrome Lancet 361 587 594 10.1016/S0140-6736(03)12518-4 12598156 (Pubitemid 36207480)
8. A Bougarit PL Toumelin C Pagnoux P Cohen A Mahr VL Guern, et al. 2005 Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients Medicine (Baltimore) 84 323 330 10.1097/01.md.0000180793.80212.17 (Pubitemid 41368485)
9. L Guillevin F Lhote M Gayraud P Cohen B Jarrousse O Lortholary, et al. 1996 Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients Medicine (Baltimore) 75 17 28 1:STN:280:DyaK287mtVentw%3D%3D 10.1097/00005792-199601000-00003 (Pubitemid 26041085)
10. JC Sisson DM Wieland P Sherman TJ Mangner MC Tobes S Jacques Jr 1987 Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function J Nucl Med 28 1620 1624 1:CAS:528:DyaL1MXmvFCrtw%3D%3D 3655914 (Pubitemid 17158138)
11. S Yamashina J Yamazaki 2007 Neuronal imaging using SPECT Eur J Nucl Med Mol Imaging 34 939 950 10.1007/s00259-006-0359-0 17268772 (Pubitemid 46798959)
12. K Watanabe T Takahashi S Miyajima Y Hirokawa N Tanabe K Kato, et al. 2002 Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina J Nucl Med 43 1476 1481 1:CAS:528: DC%2BD38XptV2mt7g%3D 12411551
13. P Merlet H Valette J Dubois-Randé D Moyse D Duboc P Dove, et al. 1992 Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure J Nucl Med 33 471 477 1:STN:280:DyaK383gt12rtA%3D%3D 1552326
14. S Kasama T Toyama H Kumakura Y Takayama S Ichikawa T Suzuki, et al. 2005 Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction J Am Coll Cardiol 45 661 667 1:CAS:528:DC%2BD2MXhslegsL0%3D 10.1016/j.jacc.2004.11. 038 15734608 (Pubitemid 40278963)
15. N Tsurikisawa M Taniguchi H Saito H Himeno A Ishibashi S Suzuki, et al. 2004 Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin Ann Allergy Asthma Immunol 92 80 87 1:CAS:528: DC%2BD2cXhsVyjtb0%3D 10.1016/S1081-1206(10)61714-0 14756469
16. AT Masi GG Hunder JT Lie BA Michel DA Bloch WP Arend, et al. 1990 The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis) Arthritis Rheum 33 1094 1100 1:STN:280:DyaK3czlvVyqsA%3D%3D 10.1002/art.1780330806 2202307
17. RA Luqmani PA Bacon RJ Moots BA Janssen A Pall P Emery, et al. 1994 Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis QJM 87 671 678 1:STN:280:DyaK2M7itVClsg%3D%3D 7820541
18. G Germano H Kiat PB Kavanagh M Moriel M Mazzanti HT Su, et al. 1995 Automatic quantification of ejection fraction from gated myocardial perfusion SPECT J Nucl Med 36 2138 2147 1:STN:280:DyaK28%2FkvFWiuw%3D%3D 7472611
19. MD Cerqueira NJ Weissman V Dilsizian AK Jacobs S Kaul WK Laskey, et al. 2002 Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 539 542 10.1161/hc0402.102975 11815441 (Pubitemid 34262671)
20. T Neumann B Manger M Schmid C Kroegel A Hansch WA Kaiser, et al. 2009 Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis Medicine (Baltimore) 88 236 243 10.1097/MD.0b013e3181af35a5
21. A Frustaci N Gentiloni C Chimenti L Natale G Gasbarrini A Maseri 1998 Necrotizing myocardial vasculitis in Churg-Strauss syndrome: clinicohistologic evaluation of steroids and immunosuppressive therapy Chest 114 1484 1489 1:STN:280:DyaK1M%2FjvFKnsQ%3D%3D 10.1378/chest.114.5.1484 9824037
22. F Terasaki T Hayashi Y Hirota M Okabe M Suwa H Deguchi, et al. 1997 Evolution to dilated cardiomyopathy from acute eosinophilic pancarditis in Churg-Strauss syndrome Heart Vessels 12 43 48 1:STN:280:DyaK2svjsVKqsw%3D%3D 10.1007/BF01747501 9288559 (Pubitemid 27371198)
23. 123I-metaiodobenzylguanidine cardiac scintigraphic study Eur Heart J 22 323 332 1:STN:280:DC%2BD3M3gsVWlsw%3D%3D 10.1053/euhj.2000.2482 11161951 (Pubitemid 32622461)
24. JD Minardo MM Tuli BH Mock RE Weiner HP Pride HN Wellman, et al. 1988 Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application Circulation 78 1008 1019 1:STN:280:DyaL1M%2FgtlCrsQ%3D%3D 3168182
25. M Kyuma T Nakata A Hashimoto K Nagao H Sasao T Takahashi, et al. 2004 Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure J Nucl Med 45 155 163 1:CAS:528:DC%2BD2cXitVCrtLk%3D 14960630
26. R Wassmuth U Göbel A Natusch W Schneider R Kettritz R Dietz, et al. 2008 Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome J Card Fail 14 856 860 10.1016/j.cardfail.2008.07.227 19041050
27. G Pelà G Tirabassi P Pattoneri L Pavone G Garini G Bruschi 2006 Cardiac involvement in the Churg-Strauss syndrome Am J Cardiol 97 1519 1524 10.1016/j.amjcard.2005.11.088 16679097
28. 13N-ammonia PET imaging for evaluation of the cardiac damage in Churg-Strauss syndrome Eur J Nucl Med Mol Imaging 31 1218 10.1007/s00259-004-1550-9 15150672
29. R Valle N Aspromonte M Feola M Milli C Canali P Giovinazzo, et al. 2005 B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function J Card Fail 11 498 503 1:CAS:528:DC%2BD2MXhtVGrtr3J 10.1016/j.cardfail.2005.05.002 16198244 (Pubitemid 41403272)
30. AF Jacobson R Senior MD Cerqueira ND Wong GS Thomas VA Lopez, et al. 2010 Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study J Am Coll Cardiol 55 2212 2221 10.1016/j.jacc.2010.01.014 20188504
31. G Germano J Erel H Kiat PB Kavanagh DS Berman 1997 Quantitative LVEF and quantitative regional function from gated thallium-201 perfusion SPECT J Nucl Med 38 749 754 1:STN:280:DyaK2szhsVSqug%3D%3D 9170440
32. E Cwajg J Cwajg ZX He WS Hwang F Keng SF Nagueh, et al. 1999 Gated myocardial perfusion tomography for the assessment of left ventricular function and volumes: comparison with echocardiography J Nucl Med 40 1857 1865 1:STN:280:DC%2BD3c%2FivFGisw%3D%3D 10565781